Jade Biosciences Inc. (AVTE)
NASDAQ · Healthcare
Jade Biosciences Inc. Operating Income 2019–2024
Jade Biosciences Inc. annual/quarterly operating income history and growth rate from 2019 to 2024. Operating income (EBIT) is profit from core business operations, excluding interest and income taxes. It reflects the efficiency of a company's core operations.
- Jade Biosciences Inc. operating income for the quarter ending December 31, 2024 was -6.4 M, a 70.98% decrease year-over-year.
- Jade Biosciences Inc. operating income for the twelve months ending December 31, 2024 was -74.6 M.
- Jade Biosciences Inc. annual operating income for 2024 was -74.6 M, a 8.37% decrease from 2023.
- Jade Biosciences Inc. annual operating income for 2023 was -81.4 M, a 52.92% increase from 2022.
- Jade Biosciences Inc. annual operating income for 2022 was -53.2 M, a 131.24% increase from 2021.
- Jade Biosciences Inc. annual operating income for 2021 was -23.0 M.
Operating Income
ANNUAL · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %
Jade Biosciences Inc. Operating Income — FAQ
Jade Biosciences Inc. (AVTE) operating income over the last 6 years — annual and quarterly figures with year-over-year growth and charts.
What is Jade Biosciences Inc.'s operating income?
Jade Biosciences Inc. (AVTE) reported operating income of -$75M for fiscal 2024.
Where can I see AVTE's operating income history?
The chart and table above show Jade Biosciences Inc.'s operating income by year and by quarter, including the growth rate.